Viewing Study NCT00002064



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002064
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: Toxoplasmic Encephalitis in Patients With AIDS Treatment and Prevention of Relapse
Sponsor: Palo Alto Medical Foundation
Organization: NIH AIDS Clinical Trials Information Service

Study Overview

Official Title: Toxoplasmic Encephalitis in Patients With AIDS Treatment and Prevention of Relapse
Status: COMPLETED
Status Verified Date: 1989-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To compare pyrimethamine and intravenous IV clindamycin vs pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system CNS Toxoplasma gondii
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: